#bladdercancer #NICErecommended #JnJ #Balversa #urothelialcancer #geneticalteration #erdafitinib #FGFR3alteration #unresectableurothelialcancer #metastaticurothelialcancer #THOrclinicaltrial #FGFR3expressingcancercellgrowth #genetictesting
pharmatimes.com/news/first-t...
pharmatimes.com/news/first-t...
First treatment for common bladder cancer recommended by NICE - PharmaTimes
Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration
pharmatimes.com
April 15, 2025 at 8:56 AM